New Pancreatic Cells for Type 1 Diabetes Control
Part of Hormones & metabolism clinical trials.
This early-stage trial tests whether transplanting special pancreatic cells can help people with type 1 diabetes better control their blood sugar and reduce dangerous low-blood-sugar episodes. The goal is to reduce your dependence on insulin injections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–65 years old and were diagnosed with type 1 diabetes before age 40
- You have been on insulin for at least 5 years
- You experience recurrent severe low-blood-sugar episodes (hypoglycemia)
- You are willing to wear and use a continuous glucose monitor (a small device that tracks blood sugar 24/7)
- You have not taken any other diabetes medications besides insulin in the last 3 months
- You have not used weight-loss medications in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment made from pig pancreatic cells (called OPF-310) that are placed under the skin to help control blood sugar in people with type 1 diabetes. It is for those whose diabetes is difficult to manage and who have dangerous low blood sugar episodes.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
This early-stage trial tests a new type of immune cell therapy (CAR-T cells) designed to stop the body's immune system from attacking insulin-producing cells in type 1 diabetes. The goal is to help preserve remaining pancreas function in people with early-stage disease.
This trial studies whether transplanting insulin-producing islet cells can improve blood sugar control and reduce severe low blood sugar in people with “brittle” type 1 diabetes. It’s meant for adults with long-standing insulin dependence and troublesome, hard-to-control hypoglycemia.
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.